comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-02 08:12:20 - browse：83739

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Ebola: Gilead Sciences antiviral shows promise as new treatment

hotspot

WSS

UnitedHealth’s Optum accused of antitrust violations in California

CDC director unscathed in first congressional testimony

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Ebola: Gilead Sciences antiviral shows promise as new treatment

Organ aging and disease risk measured by new blood test

How many hemophilia patients actually want gene therapy?

Wikipedia

comprehensive

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: CAR

Wildfire smoke exposes gaps in outdoor worker protections

WuXi out of biotech trade group, U.S. and China relations to blame

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

RaDonda Vaught links Vanderbilt hospital issues to patient death

Walensky prepares to leave CDC — and Congress — behind

John Green on his newest strategy for fighting tuberculosis

Jerome Adams on the need for new antivirals for Covid

CDC director unscathed in first congressional testimony

Wikipedia

What to do when lifesaving products contribute to climate change

Why scientists need input from humanists on sensitive research

Amid AI frenzy, a top HHS official's quest to create safeguards

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Readout Newsletter: CAR

CDC director unscathed in first congressional testimony

hotspot

hotspot

hotspot

Wikipedia